<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00523133</url>
  </required_header>
  <id_info>
    <org_study_id>R01AA012696-01A1</org_study_id>
    <nct_id>NCT00523133</nct_id>
  </id_info>
  <brief_title>Research on Individualized Treatment for Alcoholism</brief_title>
  <acronym>RITA</acronym>
  <official_title>Posttreatment Effects of Naltrexone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VA Boston Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to compare the effects of two psychosocial treatments that
      differed in scope and intensity (Broad Spectrum Treatment and Motivational Enhancement
      Treatment) combined with 3 or 6 months of treatment with naltrexone on alcohol drinking
      behaviors in alcohol dependent patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2000</start_date>
  <completion_date type="Actual">July 2005</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Days Abstinent</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Heavy Drinking Days</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">185</enrollment>
  <condition>Alcohol Dependence</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>naltrexone</intervention_name>
    <description>50 mg naltrexone daily for 3 months</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>naltrexone</intervention_name>
    <description>50 mg of naltrexone daily for 6 months</description>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Broad Spectrum Treatment</intervention_name>
    <description>8-14, one hour sessions over 6 months</description>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational Enhancement Treatment</intervention_name>
    <description>4, 20 minute sessions over 3 months</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  men and women between the ages of 21-65

          -  current DSM-IV diagnosis of alcohol dependence

          -  abstinent for a minimum of 3 and maximum of 21 days prior to treatment initiation

          -  able to participate in an 18-month outpatient study

          -  live within a one hour or less commute to Fairbanks

          -  fluent in English

          -  women of child-bearing potential must have a negative pregnancy test and use effective
             contraceptive methods.

          -  score as contemplators or greater on the Readiness For Change Scale

        Exclusion Criteria:

          -  severe hepatic disease (gGGT, SGOT or other liver functions greater than 4 times
             normal)

          -  opiate use (for any reason) in the last 14 days or a history of opioid dependence in
             the past year

          -  pregnant or lactating females or those unwilling to use birth control

          -  inability, according to the opinion of the interviewer, to follow medication
             instructions and safety precautions

          -  comorbid substance dependence (but not abuse) diagnosis in the past 6 months,
             excluding nicotine or marijuana dependence

          -  concomitant use of medications intended to decrease drinking (e.g. disulfiram)

          -  meeting current DSM criteria for bipolar disorder, schizophrenia, bulimia/anorexia,
             dementia, major depression
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dena Davidson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Psychiatry Outpatient Clinic</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2007</study_first_submitted>
  <study_first_submitted_qc>August 30, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2007</study_first_posted>
  <last_update_submitted>August 30, 2007</last_update_submitted>
  <last_update_submitted_qc>August 30, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2007</last_update_posted>
  <keyword>alcoholism</keyword>
  <keyword>naltrexone</keyword>
  <keyword>motivational enhancement therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naltrexone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

